IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy.

Helms, Mike W; Prescher, Jennifer A; Cao, Yu-An; Schaffert, Steven; Contag, Christopher H

Helms, Mike W; Prescher, Jennifer A; Cao, Yu-An; Schaffert, Steven; Contag, Christopher H.

Affiliation

Helms MW; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305-5439, USA.

Cancer Immunol Immunother ; 59(9): 1325-34, 2010 Sep.

Article in En | MEDLINE | ID: mdl-20532883

Subject(s)

Immunotherapy, Adoptive; Interleukin-12/administration & dosage; Lymphocyte Subsets/metabolism; Lymphocytes, Tumor-Infiltrating/metabolism; Mammary Neoplasms, Experimental/immunology; Animals; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Therapy, Combination; Interleukin-12/adverse effects; Killer Cells, Natural/immunology; Lymphocyte Subsets/immunology; Lymphocyte Subsets/pathology; Lymphocytes, Tumor-Infiltrating/immunology; Lymphocytes, Tumor-Infiltrating/pathology; Mammary Neoplasms, Experimental/pathology; Mammary Neoplasms, Experimental/therapy; Mice; Mice, Inbred Strains; Remission Induction; T-Lymphocytes/immunology; Time Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphocyte Subsets / Lymphocytes, Tumor-Infiltrating / Interleukin-12 / Mammary Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2010 Document type: Article Affiliation country: United States Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google